Kathryn B. McKenzie, Chief Financial Officer at NEOGENOMICS INC (NEO), sold 1,846 shares at $35.00 ($65K) on 2021-12-21, disclosed to the SEC on 2021-12-23.
Open-market sale of $65k NEO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.